Literature DB >> 1500611

Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders.

R M Rapee1, T A Brown, M M Antony, D H Barlow.   

Abstract

Anxiety disorder patients (n = 198; under criteria of the Diagnostic and Statistical Manual of Mental Disorders; rev. 3rd ed.; American Psychiatric Association, 1987) and nonanxious control subjects (n = 25) underwent challenges of 90 s of voluntary hyperventilation and 15 min of 5.5% carbon dioxide in air. Panic disorder subjects showed a greater subjective response to both challenges than did subjects with other anxiety disorders, who in turn responded more than did control subjects. Furthermore, subjects with panic disorder as an additional diagnosis tended to report more subjective response than did anxiety disorder subjects without panic disorder. The best prechallenge predictor of response to each procedure was a measure of fear of physical symptoms. The findings support previous results that have pointed to a greater fear or anxiety-inducing effect of these challenge procedures in panic disorder patients, as compared with other subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500611     DOI: 10.1037//0021-843x.101.3.538

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  19 in total

1.  Associations Between Past-Month Pain and Distress Intolerance Among Daily Cigarette Smokers.

Authors:  Lisa R LaRowe; Samantha G Farris; Michael J Zvolensky; Joseph W Ditre
Journal:  J Stud Alcohol Drugs       Date:  2018-09       Impact factor: 2.582

Review 2.  [Panic disorder and its psychological treatment].

Authors:  J Margraf; M Ruhmland
Journal:  Naturwissenschaften       Date:  1996-09

3.  The Influence of Anxiety Sensitivity on a Wish to Die in Complicated Grief.

Authors:  Amanda W Baker; Elizabeth M Goetter; Eric Bui; Riva Shah; Meredith E Charney; Christine Mauro; M Katherine Shear; Naomi M Simon
Journal:  J Nerv Ment Dis       Date:  2016-04       Impact factor: 2.254

4.  A laboratory-based test of the relation between adolescent alcohol use and panic-relevant responding.

Authors:  Heidemarie Blumenthal; Renee M Cloutier; Byron L Zamboanga; Liviu Bunaciu; Ashley A Knapp
Journal:  Exp Clin Psychopharmacol       Date:  2015-06-08       Impact factor: 3.157

5.  The Effects of Hyper- and Hypocapnia on Phonatory Laryngeal Airway Resistance in Women.

Authors:  Amanda I Gillespie; William Slivka; Charles W Atwood; Katherine Verdolini Abbott
Journal:  J Speech Lang Hear Res       Date:  2015-06       Impact factor: 2.297

6.  Avoidance of 20% carbon dioxide-enriched air with humans.

Authors:  C W Lejuez; J O'Donnell; O Wirth; M J Zvolensky; G H Eifert
Journal:  J Exp Anal Behav       Date:  1998-07       Impact factor: 2.468

7.  Heart-focused anxiety, illness beliefs, and behavioral impairment: comparing healthy heart-anxious patients with cardiac and surgical inpatients.

Authors:  G H Eifert; S E Hodson; D R Tracey; J L Seville; K Gunawardane
Journal:  J Behav Med       Date:  1996-08

Review 8.  Sex differences in salivary cortisol in response to acute stressors among healthy participants, in recreational or pathological gamblers, and in those with posttraumatic stress disorder.

Authors:  Jason J Paris; Christine Franco; Ruthlyn Sodano; Brian Freidenberg; Elana Gordis; Drew A Anderson; John P Forsyth; Edelgard Wulfert; Cheryl A Frye
Journal:  Horm Behav       Date:  2009-06-16       Impact factor: 3.587

9.  Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator.

Authors:  Frank Godemann; Christian Butter; Felix Lampe; Michael Linden; Michael Schlegl; Hans-Peter Schultheiss; Steffen Behrens
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

10.  Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patients.

Authors:  Benjamin F Rodriguez; Steven E Bruce; Maria E Pagano; Michael A Spencer; Martin B Keller
Journal:  Behav Res Ther       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.